Literature DB >> 7053596

Effects of nonsurgical coronary reperfusion on the left ventricle in human subjects compared with conventional treatment. Study of 18 patients with acute myocardial infarction treated with intracoronary infusion of streptokinase.

K P Rentrop, H Blanke, K R Karsch.   

Abstract

Left ventricular function was assessed sequentially with biplane cineventriculography in 18 patients with acute myocardial infarction, in whom nonsurgical reperfusion was achieved within 8.2 +/- 6.9 hours (mean +/- standard deviation) after the onset of chest pain with intracoronary infusion of streptokinase (2,000 units/min for 66 +/- 16 minutes). Ejection fraction increased from 51.4 +/- 9.8 percent before reperfusion to 55.9 +/- 9.0 percent immediately after completion of streptokinase infusion (n = 13, p less than 0.01); the length of the akinetic myocardial segment decreased from 10.2 +/- 6.1 to 7.1 +/- 4.9 cm (p less than 0.025). Left ventricular function data before reperfusion and in the chronic stage of infarction (before surgery) were compared with data obtained in two medically treated groups that were matched retrospectively: control group I, nine patients with permanent obstruction of the infarcted vessel; control group II, nine patients with spontaneous recanalization of the initially obstructed vessel. In the acute stage of infarction, ejection fraction and akinetic segment length were comparable in the three groups. In the chronic stage ejection fraction was higher in the study group (57.4 +/- 12.7 percent) than in control group I (43.4 +/- 7.6 percent, probability [p] less than 0.05); the akinetic segment was shorter in the study group (4.5 +/- 6 versus 9.4 +/- 5.5 cm, p less than 0.025). Preservation of R waves was more extensive in the study group. Intraoperative inspection in 10 study group patients and transmural biopsy performed in 3 of these patients revealed the bulk of reperfused myocardium to be viable. It is concluded that jeopardized myocardium was preserved by nonsurgical reperfusion during the acute stage of coronary occlusion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053596     DOI: 10.1016/0002-9149(82)90269-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Short and long term predictive value of admission wall motion score in acute myocardial infarction. A cross sectional echocardiographic study of 345 patients.

Authors:  G Kan; C A Visser; J J Koolen; A J Dunning
Journal:  Br Heart J       Date:  1986-11

2.  Pathological changes after intravenous streptokinase treatment in eight patients with acute myocardial infarction.

Authors:  S G Richardson; D C Allen; P Morton; J G Murtagh; M E Scott; D B O'Keeffe
Journal:  Br Heart J       Date:  1989-05

3.  Streptokinase, urokinase, and tissue plasminogen activator: pharmacokinetics, relative advantages, and methods for maximizing rates and consistency of lysis.

Authors:  A S Maizel; J J Bookstein
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

4.  Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction.

Authors:  R S Stack; H R Phillips; D S Grierson; V S Behar; Y Kong; R H Peter; J L Swain; J C Greenfield
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

5.  Percutaneous transluminal coronary artery recanalization in evolving myocardial infarction.

Authors:  P Rentrop; H Blanke
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

6.  The dobutamine stress test as an alternative to exercise testing after acute myocardial infarction.

Authors:  D Mannering; T Cripps; G Leech; N Mehta; H Valantine; S Gilmour; E D Bennett
Journal:  Br Heart J       Date:  1988-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.